iBio’s FastPharming Platform Produces Decoy Therapeutic to Bind to SARS-CoV-2
Factors inherent to obesity could increase vulnerability to COVID-19
Novavax Inks Deal With India For 2B Covid-19 Vaccine Doses In 2021
India Tops 5 Million COVID-19 Cases; Virus Killed 121 American Youths, CDC Reports: Live Updates
Merck Puts Focus On Lower Debt, Sees Smaller Takeovers After 2022
Why AstraZeneca and others racing to make a COVID-19 vaccine should be more open about the process
Regeneron tests COVID-19 antibody therapy in UK’s RECOVERY trial
Eyeing emergency use of COVID-19 drug, Humanigen partners with Lonza to make it
Covid-19 Vaccine Makers’ Pledge May Not Quell Uprising
Pfizer says late-stage coronavirus vaccine study shows moderate side effects
Aiming for accuracy
AstraZeneca’s Pivotal Covid-19 Vaccine Trial Kept On Hold In US- Report
Novus Therapeutics Explodes 166% On Anelixis Deal, Capital Raise
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
Monday’s Market Snapshot: Here’s What You Need To Know Right Now
Merck To Buy $1B Seattle Genetics Stake For Oncology Collab
Futures Surge On Monday Merger Mania, Fresh Vaccine Hopes
Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will
Molecular Completes Manufacturing For Covid-19 Drug, Plans Nov. Human Trial
AstraZeneca Resumes Late-Stage Covid-19 Vaccine Trials In UK
Merck starts recruitment for Covid-19 vaccine trial
Pfizer, BioNTech propose expanding CovidD-19 vaccine trial to 44,000 volunteers
AstraZeneca resumes UK trials of Covid-19 vaccine halted by patient illness
France Suffers New Record Surge In COVID-19 Cases As Locals Complain About Testing Delays: Live Updates
AstraZeneca Resumes COVID-19 Trials After Halt Over Adverse Reaction
Why Bill Gates Is Betting Millions on Synthetic Biology
GSK and J&J alum Vijay Reddy to take control of R&D at Tmunity; Andrew Hirsch exits Agios for CEO job at C4 Therapeutics
NIH launches two trials to test blood thinners in Covid-19 patients
Is Inovio Stock a Buy Right Now? This Is What You Need to Know